These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 3162758)

  • 1. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
    Zamora JM; Pearce HL; Beck WT
    Mol Pharmacol; 1988 Apr; 33(4):454-62. PubMed ID: 3162758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
    Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
    Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR
    Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT; Cirtain MC; Look AT; Ashmun RA
    Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells.
    Zamora JM; Beck WT
    Biochem Pharmacol; 1986 Dec; 35(23):4303-10. PubMed ID: 3466591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
    Inaba M; Nagashima K
    Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
    Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
    Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E; Tarasiuk J; Garnier-Suillerot A
    Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
    Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
    Hill BT; Hosking LK
    Cancer Chemother Pharmacol; 1994; 33(4):317-24. PubMed ID: 8281626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principle.
    Skovsgaard T; Danø K; Nissen NI
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():63-72. PubMed ID: 6375864
    [No Abstract]   [Full Text] [Related]  

  • 13. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT; Cirtain MC; Lefko JL
    Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics.
    Tsuruo T
    Cancer Treat Rep; 1983 Oct; 67(10):889-94. PubMed ID: 6354436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the mechanism of multidrug resistance].
    Inaba M
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):807-14. PubMed ID: 3471182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants of phenoxazine type compounds required to modulate the accumulation of vinblastine and vincristine in multidrug-resistant cell lines.
    Thimmaiah KN; Horton JK; Qian XD; Beck WT; Houghton JA; Houghton PJ
    Cancer Commun; 1990; 2(7):249-59. PubMed ID: 2378785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
    Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI
    Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines.
    Qian XD; Beck WT
    Cancer Res; 1990 Feb; 50(4):1132-7. PubMed ID: 1967551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.
    Berlion M; Arvelo F; Leonce S; Bourgeois Y; Rigaudy P; Bizzari JP; Poupon MF
    In Vivo; 1993; 7(5):399-405. PubMed ID: 7906553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of interaction of vinca alkaloids with tubulin: catharanthine and vindoline.
    Prakash V; Timasheff SN
    Biochemistry; 1991 Jan; 30(3):873-80. PubMed ID: 1988072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.